ARTICLE | Company News
Roskamp Institute neurology news
October 27, 2008 7:00 AM UTC
The Roskamp Institute spun outs its Alzheimer disease (AD) treatments into newco Archer Pharmaceuticals Inc. Archer's pipeline includes ARC029 and ARC031. The company plans to begin Phase I trials o...